Search Results - Joachim Boos
- Showing 1 - 7 results of 7
-
1
Feasibility and effects of a home-based intervention using activity trackers on achievement of individual goals, quality of life and motor performance in patients with paediatric c... by Miriam Götte, Sabine Verena Kesting, Joachim Gerss, Dieter Rosenbaum, Joachim Boos
Published in BMJ Open Sport & Exercise Medicine (2018-12-01)Get full text
Article -
2
The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia by Wing H. Tong, Rob Pieters, Hester A. de Groot-Kruseman, Wim C. J. Hop, Joachim Boos, Wim J. E. Tissing, Inge M. van der Sluis
Published in Haematologica (2014-11-01)Get full text
Article -
3
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study... by Carmelo Rizzari, Anja Möricke, Maria Grazia Valsecchi, Valentino Conter, Martin Zimmermann, Daniela Silvestri, Andishe Attarbaschi, Felix Niggli, Draga Barbaric, Jan Stary, Sarah Elitzur, Gunnar Cario, Luciana Vinti, Joachim Boos, Massimo Zucchetti, Claudia Lanvers-Kaminsky, Arend von Stackelberg, Andrea Biondi, Martin Schrappe
Published in HemaSphere (2023-06-01)Get full text
Article -
4
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated <i>E. coli</i> asparaginase in children with acute lymphocyt... by Alaeddin Khalil, Gudrun Würthwein, Jana Golitsch, Georg Hempel, Manfred Fobker, Joachim Gerss, Anja Möricke, Martin Zimmermann, Petr Smisek, Massimo Zucchetti, Christa Nath, Andishe Attarbaschi, Arend von Stackelberg, Nicola Gökbuget, Carmelo Rizzari, Valentino Conter, Martin Schrappe, Joachim Boos, Claudia Lanvers-Kaminsky
Published in Haematologica (2020-12-01)Get full text
Article -
5
Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Gl... by Anja Möricke, Carmelo Rizzari, Julia Alten, Andishe Attarbaschi, Rita Beier, Andrea Biondi, Birgit Burkhardt, Nicole Bodmer, Joachim Boos, Gunnar Cario, Valentino Conter, Christian Flotho, Andreas Kulozik, Claudia Lanvers-Kaminsky, Georg Mann, Felix Niggli, Daniela Silvestri, Arend von Stackelberg, Martin Stanulla, Maria-Grazia Valsecchi, Martin Schrappe, Martin Zimmermann
Published in HemaSphere (2023-06-01)Get full text
Article -
6
Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label,... by Ewa Koscielniak, Gustaf Ljungman, Bernarda Kazanowska, Felix Niggli, Monika Sparber-Sauer, Rupert Handgretinger, Martin Zimmermann, Joachim Boos, Bernd Blank, Erika Hallmen, Irene Teichert von Lüttichau, Irene Schmid, Birgit Fröhlich, Hermann L. Müller, Wolfgang Behnisch, Ruth Ladenstein, Monika Scheer, Christian Vokuhl, Thekla von Kalle, Claudia Blattmann, Stefan Bielack, Thomas Klingebiel
Published in EClinicalMedicine (2024-12-01)Get full text
Article -
7
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 stud... by Carmelo Rizzari, Claudia Lanvers-Kaminsky, Maria Grazia Valsecchi, Andrea Ballerini, Cristina Matteo, Joachim Gerss, Gudrun Wuerthwein, Daniela Silvestri, Antonella Colombini, Valentino Conter, Andrea Biondi, Martin Schrappe, Anja Moericke, Martin Zimmermann, Arend von Stackelberg, Christin Linderkamp, Michael C. Frühwald, Sabine Legien, Andishe Attarbaschi, Bettina Reismüller, David Kasper, Petr Smisek, Jan Stary, Luciana Vinti, Elena Barisone, Rosanna Parasole, Concetta Micalizzi, Massimo Zucchetti, Joachim Boos
Published in Haematologica (2019-09-01)Get full text
Article